HomeComparePIEJF vs JNJ

PIEJF vs JNJ: Dividend Comparison 2026

PIEJF yields 26.21% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PIEJF wins by $485277959.85M in total portfolio value
10 years
PIEJF
PIEJF
● Live price
26.21%
Share price
$39.92
Annual div
$10.47
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$485277959.87M
Annual income
$481,747,683,099,373.75
Full PIEJF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PIEJF vs JNJ

📍 PIEJF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPIEJFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PIEJF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PIEJF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PIEJF
Annual income on $10K today (after 15% tax)
$2,228.27/yr
After 10yr DRIP, annual income (after tax)
$409,485,530,634,467.70/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PIEJF beats the other by $409,485,530,633,764.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PIEJF + JNJ for your $10,000?

PIEJF: 50%JNJ: 50%
100% JNJ50/50100% PIEJF
Portfolio after 10yr
$242638979.94M
Annual income
$240,873,841,550,100.75/yr
Blended yield
99.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PIEJF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PIEJF buys
0
JNJ buys
0
No recent congressional trades found for PIEJF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPIEJFJNJ
Forward yield26.21%3.36%
Annual dividend / share$10.47$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$485277959.87M$20.0K
Annual income after 10y$481,747,683,099,373.75$827.78
Total dividends collected$485044019.43M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PIEJF vs JNJ ($10,000, DRIP)

YearPIEJF PortfolioPIEJF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$15,943$5,242.99$10,676$355.77+$5.3KPIEJF
2$32,683$15,624.08$11,407$389.39+$21.3KPIEJF
3$94,839$59,867.91$12,198$426.53+$82.6KPIEJF
4$426,193$324,715.80$13,056$467.62+$413.1KPIEJF
5$3,183,561$2,727,534.24$13,987$513.12+$3.17MPIEJF
6$41,488,693$38,082,282.90$14,998$563.56+$41.47MPIEJF
7$972,046,343$927,653,441.54$16,098$619.52+$972.03MPIEJF
8$41,664,698,437$40,624,608,850.00$17,295$681.69+$41664.68MPIEJF
9$3,299,324,082,970$3,254,742,855,642.01$18,599$750.82+$3299324.06MPIEJF
10$485,277,959,868,152$481,747,683,099,373.75$20,022$827.78+$485277959.85MPIEJF

PIEJF vs JNJ: Complete Analysis 2026

PIEJFStock

Rothschild & Co SCA provides global advisory, wealth and asset management, and merchant banking services in France, the United Kingdom, the Channel Islands, the Americas, rest of Europe, Switzerland, Australia, Asia, and internationally. The company offers merger and acquisition, strategic advisory, debt advisory and restructuring, equity advisory, and investor advisory services to large and mid-sized corporations, private equity, families, entrepreneurs, and governments. It also provides wealth management services to families, entrepreneurs, foundations, and charities; and asset management services, such as bespoke investment management and advisory services to institutional clients, financial intermediaries, and third-party distributors. In addition, the company offers merchant banking services, including corporate private equity, secondaries, multi-managers funds, co-investments, direct lending, and credit management. Rothschild & Co SCA was founded in 1838 and is headquartered in Paris, France.

Full PIEJF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PIEJF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PIEJF vs SCHDPIEJF vs JEPIPIEJF vs OPIEJF vs KOPIEJF vs MAINPIEJF vs ABBVPIEJF vs MRKPIEJF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.